Anti-Pneumolysin 抗体 (ab71811)
Key features and details
- Rabbit polyclonal to Pneumolysin
- Suitable for: WB
- Isotype: IgG
製品の概要
-
製品名
Anti-Pneumolysin antibody
Pneumolysin 一次抗体 製品一覧 -
製品の詳細
Rabbit polyclonal to Pneumolysin -
由来種
Rabbit -
アプリケーション
適用あり: WBmore details -
種交差性
交差種: Streptococcus pneumoniae -
免疫原
Recombinant full length protein
-
特記事項
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles. -
バッファー
pH: 7.50
Constituent: 0.06% Tris buffered saline -
Concentration information loading...
-
精製度
Protein A purified -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
関連製品
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab71811の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
WB | (1) |
Use at an assay dependent dilution.
|
特記事項 |
---|
WB
Use at an assay dependent dilution. |
ターゲット情報
-
細胞内局在
Plasma membrane -
参照データベース
- SwissProt: P0C2J9 Streptococcus pneumoniae
データシートおよび資料
-
Datasheet download
参考文献 (9)
ab71811 は 9 報の論文で使用されています。
- Jacques LC et al. Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin. Nat Commun 11:1892 (2020). PubMed: 32312961
- Panagiotou S et al. Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity. Sci Rep 10:17313 (2020). PubMed: 33057054
- Badgujar DC et al. Structural insights into loss of function of a pore forming toxin and its role in pneumococcal adaptation to an intracellular lifestyle. PLoS Pathog 16:e1009016 (2020). PubMed: 33216805
- Subramanian K et al. Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival. Nat Microbiol 4:62-70 (2019). PubMed: 30420782
- Ye J et al. First-In-Class Inhibitors Targeting the Interaction between Bacterial RNA Polymerase and Sigma Initiation Factor Affect the Viability and Toxin Release of Streptococcus pneumoniae. Molecules 24:N/A (2019). PubMed: 31405060
- Surve MV et al. Heterogeneity in pneumolysin expression governs the fate of Streptococcus pneumoniae during blood-brain barrier trafficking. PLoS Pathog 14:e1007168 (2018). PubMed: 30011336
- Shenoy AT et al. Severity and properties of cardiac damage caused by Streptococcus pneumoniae are strain dependent. PLoS One 13:e0204032 (2018). PubMed: 30216364
- Liu EY et al. Differences in virulence of pneumolysin and autolysin mutants constructed by insertion duplication mutagenesis and in-frame deletion in Streptococcus pneumoniae. BMC Biotechnol 14:16 (2014). WB . PubMed: 24558977
- Brown AO et al. Streptococcus pneumoniae translocates into the myocardium and forms unique microlesions that disrupt cardiac function. PLoS Pathog 10:e1004383 (2014). IHC-P, IHC-Fr . PubMed: 25232870